SCHEMBL18158232

SCHEMBL18158232

COc1cc2ncnc(Nc3cccc(Oc4ccc(Cl)cc4)c3)c2cc1OC

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.75
RET P07949 4/20 0.75
SRC P12931 3/20 0.75
EGFR P00533 15/20 0.73
KDM4E B2RXH2 3/20 0.73
MAPT P10636 3/20 0.73
MAPK1 P28482 3/20 0.73
MAPK14 Q16539 3/20 0.73
ABL1 P00519 2/20 0.73
CYP1A2 P05177 2/20 0.73
CYP3A4 P08684 2/20 0.73
FBP1 P09467 2/20 0.73
CYP2D6 P10635 2/20 0.73
MKNK1 Q9BUB5 2/20 0.73
MEN1 O00255 1/20 0.73
GMNN O75496 1/20 0.73
ALDH1A1 P00352 1/20 0.73
LMNA P02545 1/20 0.73
RAF1 P04049 1/20 0.73
TP53 P04637 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18158234 0.92 EGFR (0.83) KDRRETSRCEGFRKDM4E
SCHEMBL18158215 0.91 EGFR (0.82) KDRRETSRCEGFRKDM4E
Hydrochloric Acid SCHEMBL8811926 0.90 EGFR (0.80) KDRRETSRCEGFRKDM4E
SCHEMBL8933814 0.90 KDR (0.88) KDRRETSRCEGFRKDM4E
Hydrochloric Acid SCHEMBL8808201 0.89 KDR (0.86) KDRRETSRCEGFRKDM4E
SCHEMBL26731862 0.87 EGFR (0.79) KDRRETSRCEGFRKDM4E
SCHEMBL5474772 0.86 KDR (1.00) KDRRETSRCEGFRKDM4E
SCHEMBL18158231 0.86 EGFR (0.83) KDRRETSRCEGFRKDM4E
Tyrphostin Ag-1478 SCHEMBL31079458 0.85 EGFR (1.00) KDRRETSRCEGFRKDM4E
Hydrochloric Acid SCHEMBL5483854 0.85 KDR (0.97) KDRRETSRCEGFRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10548897-B2 KSR antagonists ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2020-02-04 US disclosed
WO-2016168704-A1 KSR ANTAGONISTS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2016-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10548897-B2 KSR antagonists KSR1, KSR2, KRAS KDR 1123/4885RET 321/4885SRC 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.